Clinical Trials Logo

Filter by:
NCT ID: NCT05635487 Recruiting - Clinical trials for HER2-positive Breast Cancer

A Study of SHR-A1811 Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients

Start date: March 16, 2023
Phase: Phase 2
Study type: Interventional

This is a single-arm, phase II trial evaluating the efficacy and safety of SHR-A1811 combined with pyrotinib maleate in Stage II-III HER2-positive breast cancer. Subjects will receive the neoadjuvant therapy of SHR-A1811 and pyrotinib for six cycles, and then undergo surgery within 4 weeks after neoadjuvant therapy. Efficacy will be assessed every 2 cycles.

NCT ID: NCT05635435 Recruiting - Glioma Clinical Trials

Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes

Start date: October 13, 2006
Phase:
Study type: Observational

Our study considered the relevant immune and inflammatory indices, such as immunoglobulin kappa light chain, TNF, and CD4+ Helper T lymphocyte% in a multi-institutional study with a large patient cohort (n=1282) from the east, northeast, and southeast of China. Our study shed light on the association of peripheral immune system status with prognosis, tumor grade, and subtype of glioma, which can potentially benefit future diagnostic and prognostic processes of glioma given its noninvasive nature. Moreover, the preoperative inflammatory status can be leveraged for timely interventions to reverse the immunosuppressive status of cancer patients and enhance anti-tumour immunity of glioma.

NCT ID: NCT05635279 Recruiting - Clinical trials for Hepatocellular Carcinoma

Effect of Nutritional Indices on the Prognosis of HCC Patients

Start date: November 1, 2022
Phase:
Study type: Observational

Primary liver cancer has recently ranked among the leading causes of cancer death, with hepatocellular carcinoma (HCC) accounting for 75%-85% of these cases. In recent years, immune checkpoint inhibitors (ICIs) combined with tyrosine kinase inhibitors (TKIs) have achieved good results in the treatment of advanced HCC patients. So far, there is a lack of studies exploring the relationship between nutritional index and the prognosis of HCC patients treated with ICIs combined with TKIs, and there are few studies on the prognostic value of nutritional index in HCC patients treated with transarterial chemoembolization (TACE). This retrospective study aims to analyze the prognostic value of prognostic nutritional index(PNI),body mass index (BMI), psoas muscle index(PMI)and geriatric nutritional risk index (GNRI) in HCC patients who received ICIs combined with TKIs or TACE, and to provide reference for the selection of nutritional intervention programs for HCC patients.

NCT ID: NCT05635149 Recruiting - Clinical trials for Colorectal Adenocarcinoma

Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study was an observational cohort study to investigate the efficacy predictors of fuquinitinib combined with anti-PD-1 monoclonal antibody for third-line treatment and above in Chinese patients with advanced colorectal cancer.

NCT ID: NCT05635123 Recruiting - Cervical Cancer Clinical Trials

A Cohort Study of Uterine Malignancies

Start date: September 15, 2023
Phase:
Study type: Observational

The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.

NCT ID: NCT05634941 Recruiting - Depression Clinical Trials

Effect of ON-tDCS on Memory Function Improvement and Related Circuits in Stable Depression Patients

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

So far, antidepressant drugs have limited memory improvement. Transcranial direct current stimulation, as a non-invasive and safe neuroregulatory technique, is a new direction to improve memory.In this study, transcranial direct current stimulation of the greater occipital nerve was used to explore the effect of improving memory function in patients with stable depression, and related studies were conducted on the locus coeruleus-noadrenal loop and the functional connection between locus coeruleus, hippocampus and amygdala.

NCT ID: NCT05634928 Recruiting - Clinical trials for Thrombotic Microangiopathies

Construction of a Database for TMA

Start date: December 1, 2022
Phase:
Study type: Observational [Patient Registry]

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.

NCT ID: NCT05634915 Recruiting - Acute Leukemia Clinical Trials

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Start date: December 20, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this prospective, open-label, pairing design, single-center study is to evaluate the effect of individualized rATG dosing vs traditional weight-based rATG dosing regimen(10mg/kg)for patients with acute leukemia undergoing a myeloablative conditioning regimen and haploidentical hematopoietic stem cell transplantation (haplo-HSCT).

NCT ID: NCT05634798 Recruiting - Clinical trials for Endometrial Neoplasms

An Observational Study Based on Endometrial Cancer Risk Screening Model

Start date: December 1, 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to test the efficiency of our endometrial cancer risk screening calculator, and improve the endometrial cancer risk screening model to form a stable and reliable non-invasive auxiliary diagnostic tool with high sensitivity and specificity in healthy women.The main question it aims to answer is: ·the efficiency of our endometrial cancer risk screening calculator Participants will be collected demographic information, as well as ultrasound, blood routine test and other test results, which will be entered into the endometrial cancer risk screening calculator to obtain high-risk or low-risk prediction results.

NCT ID: NCT05634694 Recruiting - Cholangiocarcinoma Clinical Trials

Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients

Start date: November 30, 2022
Phase:
Study type: Observational

This is a single-center, prospective, observational and exploratory clinical study. The object of this study is to evaluate the consistency and accuracy of patient-derived organoid model of cholangiocarcinoma to predict the clinical chemotherapeutic efficacy, as well as the possibility of guiding the adjuvant chemotherapy.